Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Impact of Pulmonary Hypertension Hemodynamic Status on Long-Term Outcome After Transcatheter Aortic Valve Replacement.

Schewel J, Schmidt T, Kuck KH, Frerker C, Schewel D.

JACC Cardiovasc Interv. 2019 Nov 11;12(21):2155-2168. doi: 10.1016/j.jcin.2019.08.031.

PMID:
31699377
2.

Early Hemodynamic Changes and Long-Term Outcome Of Patients With Severe Low Gradient Aortic Stenosis After Transcatheter Aortic Valve Replacement.

Schewel J, Schlüter M, Schmidt T, Kuck KH, Frerker C, Schewel D.

EuroIntervention. 2019 Oct 1. pii: EIJ-D-19-00399. doi: 10.4244/EIJ-D-19-00399. [Epub ahead of print]

3.

Predictive impact of previous coronary artery bypass grafting on mortality after MitraClip implantation for ischemic functional mitral regurgitation.

Kitamura M, Kaneko H, Schlüter M, Schewel D, Schmidt T, Alessandrini H, Kreidel F, Okamoto M, Neuss M, Butter C, Kuck KH, Frerker C.

Int J Cardiol. 2019 Jun 15;285:21-26. doi: 10.1016/j.ijcard.2019.02.045. Epub 2019 Mar 1.

PMID:
30871803
4.

The impact of biventricular heart failure on outcomes after transcatheter aortic valve implantation.

Schmidt T, Bohné M, Schlüter M, Kitamura M, Wohlmuth P, Schewel D, Schewel J, Schmoeckel M, Kuck KH, Frerker C.

Clin Res Cardiol. 2019 Jul;108(7):741-748. doi: 10.1007/s00392-018-1400-6. Epub 2018 Dec 3.

PMID:
30506481
5.

Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres.

Kitamura M, Kaneko H, Schlüter M, Schewel D, Schmidt T, Alessandrini H, Kreidel F, Neuss M, Butter C, Kuck KH, Frerker C.

Clin Res Cardiol. 2019 Mar;108(3):264-272. doi: 10.1007/s00392-018-1352-x. Epub 2018 Aug 10.

PMID:
30097683
6.

Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry.

Kuhn C, Frerker C, Meyer AK, Kurz T, Schäfer U, Deuschl F, Abdel-Wahab M, Schewel D, Elghalban A, Kuck KH, Frey N, Frank D.

EuroIntervention. 2018 Jun 8;14(3):e301-e305. doi: 10.4244/EIJ-D-17-01153.

7.

Correlation of tricuspid regurgitation and new pacemaker implantation in patients undergoing transcatheter aortic valve implantation.

Schewel D, Schewel J, Schlüter M, Kreidel F, Schmidt T, Schmoeckel M, Elsässer A, Kuck KH, Frerker C.

Int J Cardiol. 2018 Jun 15;261:37-41. doi: 10.1016/j.ijcard.2018.03.030. Epub 2018 Mar 13.

PMID:
29572082
8.

Impact of interaction of diabetes mellitus and impaired renal function on prognosis and the incidence of acute kidney injury in patients undergoing transcatheter aortic valve replacement (TAVR).

Schewel D, Zavareh M, Schewel J, Thielsen T, Schmidt T, Schäfer U, Kuck KH, Frerker C.

Int J Cardiol. 2017 Apr 1;232:147-154. doi: 10.1016/j.ijcard.2017.01.038. Epub 2017 Jan 7.

PMID:
28089458
9.

Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria.

Frerker C, Schmidt T, Schlüter M, Bader R, Schewel J, Schewel D, Thielsen T, Kreidel F, Alessandrini H, Schlingloff F, Schäfer U, Kuck KH.

EuroIntervention. 2016 Dec 20;12(12):1520-1526. doi: 10.4244/EIJ-D-16-00209.

10.

Histological Findings and Predictors of Cerebral Debris From Transcatheter Aortic Valve Replacement: The ALSTER Experience.

Schmidt T, Akdag O, Wohlmuth P, Thielsen T, Schewel D, Schewel J, Alessandrini H, Kreidel F, Bader R, Romero M, Ladich E, Virmani R, Schäfer U, Kuck KH, Frerker C.

J Am Heart Assoc. 2016 Nov 10;5(11). pii: e004399.

11.

Histology of debris captured by a cerebral protection system during transcatheter valve-in-valve implantation.

Schmidt T, Schlüter M, Alessandrini H, Akdag O, Schewel D, Schewel J, Thielsen T, Kreidel F, Bader R, Romero M, Ladich E, Virmani R, Schäfer U, Kuck KH, Frerker C.

Heart. 2016 Oct 1;102(19):1573-80. doi: 10.1136/heartjnl-2016-309597. Epub 2016 May 24.

PMID:
27220695
12.

Reply: von Willebrand Disease After TAVR: The Missing Link?

Spangenberg T, Budde U, Schewel D, Frerker C, Thielsen T, Kuck KH, Schäfer U.

JACC Cardiovasc Interv. 2015 Aug 17;8(9):1266-1267. doi: 10.1016/j.jcin.2015.06.007. No abstract available.

13.

Invasive hemodynamic assessments during transcatheter aortic valve implantation: comparison of patient outcomes in higher vs. lower transvalvular gradients with respect to left ventricular ejection fraction.

Schewel J, Schewel D, Frerker C, Wohlmuth P, Kuck KH, Schäfer U.

Clin Res Cardiol. 2016 Jan;105(1):59-71. doi: 10.1007/s00392-015-0889-1. Epub 2015 Jul 16.

PMID:
26175117
14.

Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement.

Spangenberg T, Budde U, Schewel D, Frerker C, Thielsen T, Kuck KH, Schäfer U.

JACC Cardiovasc Interv. 2015 Apr 27;8(5):692-700. doi: 10.1016/j.jcin.2015.02.008.

15.

Expansion of the indication of transcatheter aortic valve implantation--feasibility and outcome in "off-label" patients compared with "on-label" patients.

Frerker C, Schewel J, Schewel D, Wohlmuth P, Schmidt T, Kreidel F, Bader R, Kuck KH, Schäfer U.

J Invasive Cardiol. 2015 May;27(5):229-36.

16.

Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis.

Frerker C, Schewel J, Schlüter M, Schewel D, Ramadan H, Schmidt T, Thielsen T, Kreidel F, Schlingloff F, Bader R, Wohlmuth P, Schäfer U, Kuck KH.

EuroIntervention. 2016 Apr 20;11(13):1530-6. doi: 10.4244/EIJY15M03_03.

17.

Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis.

Voigtländer L, Schewel J, Martin J, Schewel D, Frerker C, Wohlmuth P, Thielsen T, Kuck KH, Schäfer U.

Int J Cardiol. 2015 Jan 15;178:275-81. doi: 10.1016/j.ijcard.2014.10.172. Epub 2014 Oct 28.

PMID:
25464269
18.

Erratum to: Impact of transcatheter aortic valve implantation (TAVI) on pulmonary hyper-tension and clinical outcome in patients with severe aortic valvular stenosis.

Schewel D, Schewel J, Martin J, Voigtländer L, Frerker C, Wohlmuth P, Thielsen T, Kuck KH, Schäfer U.

Clin Res Cardiol. 2015 Feb;104(2):196. doi: 10.1007/s00392-014-0795-y. No abstract available.

PMID:
25408113
19.

Impact of transcatheter aortic valve implantation (TAVI) on pulmonary hyper-tension and clinical outcome in patients with severe aortic valvular stenosis.

Schewel D, Schewel J, Martin J, Voigtländer L, Frerker C, Wohlmuth P, Thielsen T, Kuck KH, Schäfer U.

Clin Res Cardiol. 2015 Feb;104(2):164-74. doi: 10.1007/s00392-014-0772-5. Epub 2014 Nov 4. Erratum in: Clin Res Cardiol. 2015 Feb;104(2):196. Clin Res Cardiol. 2015 Feb;104(2):196.

PMID:
25367243
20.

Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip.

Schäfer U, Frerker C, Thielsen T, Schewel D, Bader R, Kuck KH, Kreidel F.

EuroIntervention. 2015 Dec;11(8):942-7. doi: 10.4244/EIJY14M08_13.

21.

Balloon-expandable valves for degenerated mitral xenografts or failing surgical rings.

Schäfer U, Bader R, Frerker C, Schewel D, Thielsen T, Schmoeckel M, Kreidel F, Kuck KH.

EuroIntervention. 2014 Jun;10(2):260-8. doi: 10.4244/EIJV10I2A42.

22.

Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.

Schewel D, Frerker C, Schewel J, Wohlmuth P, Meincke F, Thielsen T, Kreidel F, Kuck KH, Schäfer U.

Catheter Cardiovasc Interv. 2015 Feb 15;85(3):502-14. doi: 10.1002/ccd.25295. Epub 2013 Dec 31.

PMID:
24259366
23.

Transfemoral and transseptal valve-in-valve implantation into a failing mitral xenograft with a balloon-expandable biological valve.

Schaefer U, Frerker C, Schewel D, Thielsen T, Meincke F, Kreidel F, Kuck KH.

Ann Thorac Surg. 2012 Dec;94(6):2115-8. doi: 10.1016/j.athoracsur.2012.04.123.

PMID:
23176928
24.

Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation.

Frerker C, Schewel D, Kuck KH, Schäfer U.

Catheter Cardiovasc Interv. 2013 Mar;81(4):592-602. doi: 10.1002/ccd.24515. Epub 2012 Nov 14.

PMID:
22707413
25.

Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach".

Schäfer U, Ho Y, Frerker C, Schewel D, Sanchez-Quintana D, Schofer J, Bijuklic K, Meincke F, Thielsen T, Kreidel F, Kuck KH.

JACC Cardiovasc Interv. 2012 May;5(5):477-486. doi: 10.1016/j.jcin.2011.11.014.

26.

Successful reposition and treatment of severe aortic paraprosthetic regurgitation after percutaneous implantation of a self-expandable biological valve.

Frerker C, Bergmann M, Schewel D, Busse C, Jensen F, Schmoeckel M, Schneider C, Kuck KH, Schaefer U.

J Cardiovasc Med (Hagerstown). 2012 May;13(5):346-50. doi: 10.2459/JCM.0b013e32833a0a43. No abstract available.

PMID:
20479655
27.

[Percutaneous approaches for mitral valve interventions--a real alternative technique for standard cardiac surgery?].

Frerker C, Schäfer U, Schewel D, Krüger M, Malisius R, Schneider C, Geidel S, Bergmann M, Kuck KH.

Herz. 2009 Sep;34(6):444-50. doi: 10.1007/s00059-009-3280-z. Review. German.

PMID:
19784562

Supplemental Content

Loading ...
Support Center